USFDA gives nod to Granules India for generic antidepressant drug

The company’s product is a generic version of Bausch Health US, LLC’s Wellbutrin XL extended-release tablets.

256
USFDA Approval
USFDA Approval

Last Updated on October 10, 2024 by The Health Master

Hyderabad : Drug firm Granules India announced that it has received USFDA approval to market Bupropion Hydrochloride extended-release tablets, an antidepressant medication to treat major depressive disorder and seasonal affective disorder.

Granules Pharmaceuticals, Inc (GPI), a wholly-owned subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) to market the product in strengths of 150 mg and 300 mg,” the drug firm said in a statement.

The company’s product is a generic version of Bausch Health US, LLC’s Wellbutrin XL extended-release tablets.

Commenting on the approval Priyanka Chigurupati, Executive Director, GPI, said “We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within the first review cycle of 10 months from filing date.

This product will be a valuable addition to our growing modified release product portfolio in the US market.”

GPI has a total of 50 ANDA approvals from US FDA (48 Final approvals and 2 tentative approvals).

USFDA gives tentative nod to Alembic for Fesoterodine fumarate extended-release tablets

USFDA gives nod to Granules Pharma for potassium chloride for oral solution

USFDA gives nod to Glenmark this for Blood Pressure drug

USFDA gives Orphan Drug Designation to Eplontersen

USFDA’s response on Chronic Cough treatment

USFDA gives nod to FDC for Ofloxacin Otic Solution

NPPA extends trade margin capping on these 5 Medical Devices

Pharma Companies to pay $590 mn to US Native Americans over opioids

USFDA gives tentative nod to Alembic for Fesoterodine fumarate extended-release tablets

Freebies to doctors at your own cost, Pharma companies told

Panacea sells domestic formulation assets to Mankind Pharma

Pharma distributor among 3 held for illegal sale of Anesthetic drugs

IPC flags safety alert against most common Drug Ibuprofen – NSAID

Govt invites third round of applications under PLI Scheme for domestic API manufacturing

USFDA issues 3 observations to Granules Pharmaceuticals Inc

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news